Aliza Alter, MD
Neurology with Special Qualifications in Child Neurology · Livingston, NJNPI 1457794257
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 43 manufacturers reported payments, led by UCB Biosciences Inc. at 35.9% of the total. 2025 is the largest year on record at $4,144, more than ten times the $15 reported in 2019. Among neurology with special qualifications in child neurology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 221 payments — averaging $40.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB Biosciences Inc.$3K
- H. Lundbeck A S$2K
- Supernus Pharmaceuticals, Inc.$727
- Neuropace, Inc.$320
- AbbVie$310
- SK Life Science, Inc.$310
- plus $2K from 37 others
Across 19 payments — averaging $757.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Immedica Pharma US, Inc.$14K
What the payments were for
- Speaking & faculty fees$3,20736%
- Travel & lodging$1,61418%
- Food & beverage$4,12046%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fintepla$3,207
- QELBREE$378
- RNS Neurostimulator Kit$162
How this compares
$8,941 in reported general payments places this provider in the 95th percentile of 69 neurology with special qualifications in child neurology providers in New Jersey.
See all neurology with special qualifications in child neurology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lorazepam | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Livingston
- Puja JoshiLivingston$724
- Juliann PaolicchiHackensack$80K
- Trevor DesouzaMorristown$14K
- Rao PasupuletiHamilton$11K
- Sara RubensteinHackensack$7K
- Carlos LastraNew Brunswick$5K
- Jacqueline RomeroMarlboro$4K
- Sohum TrivediMarlboro$4K
- Romana KulikovaGarwood$4K
- Rajeshwari MahalinghamNew Brunswick$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.